Yourgene Health expands DPYD genotyping assay to 19 variants for safer chemotherapy prescribing
Yourgene Health (part of the Novacyt Group) has launched the Yourgene® Insight DPYD assay, an enhanced pharmacogenetic test designed to identify cancer patients at risk of severe toxicity from fluoropyrimidine-based chemotherapy.











